Cargando…
A small molecule NRF2 activator BC-1901S ameliorates inflammation through DCAF1/NRF2 axis
NRF2 is a master regulator of cellular anti-oxidant and anti-inflammatory responses, and strategies to augment NRF2-dependent responses may beneficial in many diseases. Basal NRF2 protein level is constrained by constitutive KEAP1-mediated degradation, but in the presence of electrophiles, NRF2 ubiq...
Autores principales: | Chen, Yanwen, Evankovich, John W., Lear, Travis B., Tuncer, Ferhan, Kennerdell, Jason R., Camarco, Daniel P., Shishido, Morgan S., Liu, Yuan, Chen, Bill B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068124/ https://www.ncbi.nlm.nih.gov/pubmed/32171724 http://dx.doi.org/10.1016/j.redox.2020.101485 |
Ejemplares similares
-
A Repurposed Drug Screen for Compounds Regulating Aquaporin 5 Stability in Lung Epithelial Cells
por: Villandre, John, et al.
Publicado: (2022) -
A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry
por: Chen, Yanwen, et al.
Publicado: (2021) -
A high throughput screen for TMPRSS2 expression identifies FDA-approved and clinically advanced compounds that can limit SARS-CoV-2 entry
por: Chen, Yanwen, et al.
Publicado: (2020) -
A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistance
por: Liu, Yuan, et al.
Publicado: (2021) -
Modulation of lysosomal function as a therapeutic approach for coronaviral infections
por: Liu, Yuan, et al.
Publicado: (2021)